Skip to main content
Livermore
Livermore
ZHEN

Drugs Made In America Acquisition II Corp.

DMIIR
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002040475

No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $3.25M in total; no superinvestor holds it.

Other share classesDMIIDMIIU

Q4 2025 vs. Q3 2025

How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of DMIIR: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders047+47
Shares031.8M+31.8M
Value$0$4.42M+$4.42M

New holders (47)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to DMIIR in Q4 2025
InstitutionSharesValue% of portfolio
Magnetar Financial LLC2,700,000$378.0K0.00%
Vivaldi Asset Management, LLC2,068,118$289.5K0.02%
Hudson Bay Capital Management LP1,969,030$275.7K0.00%
Glazer Capital, LLC1,899,899$266.0K0.01%
Toronto Dominion Bank1,633,000$228.6K0.00%
Millennium Management LLC1,500,000$210.0K0.00%
Polar Asset Management Partners Inc.1,500,000$210.0K0.00%
Tenor Capital Management Co., L.P.1,500,000$210.0K0.00%
HGC Investment Management Inc.1,230,980$172.3K0.04%
CNH Partners LLC1,151,400$161.2K0.00%
Aristeia Capital LLC1,100,000$154.0K0.00%
D. E. Shaw & Co., Inc.1,000,000$140.0K0.00%
Omers Administration Corp1,000,000$140.0K0.00%
Davidson Kempner Capital Management LP1,000,000$140.0K0.00%
Picton Mahoney Asset Management875,000$122.5K0.00%
Linden Advisors LP899,899$117.1K0.00%
Context Capital Management, LLC750,000$105.0K0.00%
Moore Capital Management, LP750,000$105.0K0.00%
Ghisallo Capital Management LLC750,000$105.0K0.00%
Radcliffe Capital Management, L.P.575,000$74.8K0.00%
Shaolin Capital Management LLC525,000$73.5K0.00%
Wolverine Asset Management LLC505,057$70.7K0.00%
HBK Investments L P500,000$70.0K0.00%
Whitebox Advisors LLC450,000$63.0K0.00%
Wealthspring Capital LLC408,950$57.3K0.01%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys400,000$56.0K0.00%
BNP Paribas Arbitrage, SA348,600$48.8K0.00%
Lineage Point Capital LP330,000$46.2K0.02%
Alpine Global Management, LLC300,000$42.0K0.01%
Sona Asset Management (US) LLC300,000$42.0K0.00%
K2 Principal Fund, L.P.250,000$35.0K0.00%
Mint Tower Capital Management B.V.250,000$35.0K0.00%
Periscope Capital Inc.250,000$35.0K0.01%
Verition Fund Management LLC200,000$28.0K0.00%
JPMorgan Chase & Co129,630$18.1K0.00%
DLD Asset Management, LP112,200$15.7K0.00%
PEAK6 LLC100,000$14.0K0.00%
Cable Car Capital LLC100,000$14.0K0.00%
Quarry LP80,900$11.3K0.00%
Meteora Capital, LLC60,000$8.40K0.00%
Royal Bank of Canada58,000$8.00K0.00%
Harraden Circle Investments, LLC50,000$7.00K0.00%
Deltec Asset Management LLC44,500$6.23K0.00%
Abc Arbitrage SA40,000$5.60K0.00%
Clear Street Group Inc.27,259$3.82K0.00%
Highbridge Capital Management LLC1,003$1400.00%
CSS LLC80,600––

Sold out (0)

Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q3 2025 and filed for Q4 2025 without it.

None.